Activating Mutations in the Gene Encoding the ATP-Sensitive Potassium-Channel Subunit Kir6.2 and Permanent Neonatal Diabetes
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients with permanent neonatal diabetes usually present within the first three months of life and require insulin treatment. In most, the cause is unknown. Because ATP-sensitive potassium (K(ATP)) channels mediate glucose-stimulated insulin secretion from the pancreatic beta cells, we hypothesized that activating mutations in the gene encoding the Kir6.2 subunit of this channel (KCNJ11) cause neonatal diabetes. METHODS: We sequenced the KCNJ11 gene in 29 patients with permanent neonatal diabetes. The insulin secretory response to intravenous glucagon, glucose, and the sulfonylurea tolbutamide was assessed in patients who had mutations in the gene. RESULTS: Six novel, heterozygous missense mutations were identified in 10 of the 29 patients. In two patients the diabetes was familial, and in eight it arose from a spontaneous mutation. Their neonatal diabetes was characterized by ketoacidosis or marked hyperglycemia and was treated with insulin. Patients did not secrete insulin in response to glucose or glucagon but did secrete insulin in response to tolbutamide. Four of the patients also had severe developmental delay and muscle weakness; three of them also had epilepsy and mild dysmorphic features. When the most common mutation in Kir6.2 was coexpressed with sulfonylurea receptor 1 in Xenopus laevis oocytes, the ability of ATP to block mutant K(ATP) channels was greatly reduced. CONCLUSIONS: Heterozygous activating mutations in the gene encoding Kir6.2 cause permanent neonatal diabetes and may also be associated with developmental delay, muscle weakness, and epilepsy. Identification of the genetic cause of permanent neonatal diabetes may facilitate the treatment of this disease with sulfonylureas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“can be treated with high-dose sulfonylureas despite being insulin dependent also provide a compelling case for genetic evaluation of monogenic diabetes with therapeutic and prognostic implications ( 2 – 6 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Findings that neonatal diabetes is most commonly due to activating mutations in genes encoding the ATP-sensitive potassium channel subunits Kir6.2 or SUR1”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Reconstitution of I KATP : An Inward Rectifier Subunit Plus the Sulfonylurea Receptor
Inagaki, N., Gonoi, T., Clement, J. P., Namba, N., Inazawa, J., Gonzalez, G., Aguilar-Bryan, L., Seino, S., & Bryan, J. (1995) · Science · doi:10.1126/science.270.5239.1166 · Cited by 1,709
Cross sectional stature and weight reference curves for the UK, 1990.
Freeman, J. V., Cole, T. J., Chinn, S., Jones, P. R., White, E. M., & Preece, M. A. (1995) · Archives of Disease in Childhood · doi:10.1136/adc.73.1.17 · Cited by 1,457
Stoffers, D. A., Zinkin, N. T., Stanojevic, V., Clarke, W. L., & Habener, J. F. (1997) · Nature Genetics · doi:10.1038/ng0197-106 · Cited by 1,106
Delépine, M., Nicolino, M., Barrett, T., Golamaully, M., Mark Lathrop, G., & Julier, C. (2000) · Nature Genetics · doi:10.1038/78085 · Cited by 813
Crystal Structure of the Potassium Channel KirBac1.1 in the Closed State
Kuo, A., Gulbis, J. M., Antcliff, J. F., Rahman, T., Lowe, E. D., Zimmer, J., Cuthbertson, J., Ashcroft, F. M., Ezaki, T., & Doyle, D. A. (2003) · Science · doi:10.1126/science.1085028 · Cited by 785
Self-citationGloyn, A. L., Weedon, M. N., Owen, K. R., Turner, M. J., Knight, B. A., Hitman, G., Walker, M., Levy, J. C., Sampson, M., Halford, S., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.568 · Cited by 754
Self-citationAssociation and Stoichiometry of KATP Channel Subunits
Clement, J. P., Kunjilwar, K., Gonzalez, G., Schwanstecher, M., Panten, U., Aguilar-Bryan, L., & Bryan, J. (1997) · Neuron · doi:10.1016/s0896-6273(00)80321-9 · Cited by 692
Genetic cause of hyperglycaemia and response to treatment in diabetes
Pearson, E. R., Starkey, B. J., Powell, R. J., Gribble, F. M., Clark, P. M., & Hattersley, A. T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14571-0 · Cited by 607
Self-citationMutations in the glucokinase gene of the fetus result in reduced birth weight
Hattersley, A. T., Beards, F., Ballantyne, E., Appleton, M., Harvey, R., & Ellard, S. (1998) · Nature Genetics · doi:10.1038/953 · Cited by 594
Self-citation
Cited by
Items 301–400 of 1,000
CRISPR-based genome editing in primary human pancreatic islet cells
Bevacqua, R. J., Dai, X.-Q., Lam, J. Y., Gu, X., Friedlander, M. S. H., Tellez, K., Miguel-Escalada, I., Bonàs‐Guarch, S., Atla, G., Zhao, W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22651-w · Cited by 56
The use of precision diagnostics for monogenic diabetes: a systematic review and expert opinion
Murphy, R., Colclough, K., Pollin, T. I., Iklé, J. M., Svalastoga, P., Maloney, K. A., Saint‐Martin, C., Molnes, J., PMDI, A., Tobias, D. K., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00369-8 · Cited by 58
“Median score for the discovery group was 8 (0-24), with a higher median score of 12 (6-22) in HNF1B.”
BackgroundSelf-citationPhase Transitions in the Multi-cellular Regulatory Behavior of Pancreatic Islet Excitability
Hraha, T. H., Westacott, M. J., Pozzoli, M., Notary, A. M., McClatchey, P. M., & Benninger, R. K. P. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003819 · Cited by 58
“2 or SUR1 KATP channel subunits [8,38].”
BackgroundKATP-channels in beta-cells in tissue slices are directly modulated by millimolar ATP.
Speier, S., Yang, S.-B., Sroka, K., Rose, T., & Rupnik, M. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2004.11.002 · Cited by 53
“Hyperactivity of ATP-channels results in reduced excitability and impaired elease of insulin (Koster et al., 2000; Gloyn et al., 2004). ulfonylureas block KATP-channels, bypassing metabolic efects and effectively augment the insulin secretion in on-insulin-dependent diabetes (Sturgess et al., 1985;…”
Type 2 Diabetes-Associated Genetic Polymorphisms as Potential Disease Predictors
Witka, B. Z., Oktaviani, D. J., Marcellino, M., Barliana, M. I., & Abdulah, R. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s230061 · Cited by 60
“2 is also expressed in neurons, the brain, and muscles.(156)”
Mackay, D., Temple, I. K., Hamilton-Shield, J. P., & Robinson, D. (2005) · Human Genetics · doi:10.1007/s00439-004-1236-1 · Cited by 53
“They were also negative for mutations in the KCNJ11 gene, which has been shown to cause neonatal diabetes (Gloyn et al. 2004).”
BackgroundSelf-citationPharmacological rescue of trafficking-impaired ATP-sensitive potassium channels
Martin, G. M., Chen, P., Devaraneni, P. K., & Shyng, S. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00386 · Cited by 62
Moriguchi, S., Ishizuka, T., Yabuki, Y., Shioda, N., Sasaki, Y., Tagashira, H., Yawo, H., Yeh, J. Z., Sakagami, H., Narahashi, T., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.187 · Cited by 57
Türkkahraman, D., Bircan, İ., Tribble, N. D., Akçurin, S., Ellard, S., & Gloyn, A. L. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.12.037 · Cited by 56
Self-citationMechanism of action of a sulphonylurea receptor SUR1 mutation (F132L) that causes DEND syndrome
Proks, P., Shimomura, K., Craig, T. J., Girard, C. A. J., & Ashcroft, F. M. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm149 · Cited by 52
Self-citationKir6.2 mutations causing neonatal diabetes prevent endocytosis of ATP-sensitive potassium channels
Mankouri, J., Taneja, T. K., Smith, A. J., Ponnambalam, S., & Sivaprasadarao, A. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601275 · Cited by 51
“2, Y330C and F333I, which cause severe forms of PNDM with blood glucose levels approaching as high as 70mM.”
BackgroundInfluentialGajdos, Z. K. Z., Butler, J. L., Henderson, K. D., He, C., Supelak, P. J., Egyud, M., Price, A., Reich, D., Clayton, P. E., Le Marchand, L., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0981 · Cited by 52
Aaboe, K., Knop, F. K., Vilsboll, T., Vølund, A., Simonsen, U., Deacon, C. F., Madsbad, S., Holst, J. J., & Krarup, T. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1731 · Cited by 53
“diabetes presenting within the first 3 months of life (10).”
BackgroundControl of Inward Rectifier K Channel Activity by Lipid Tethering of Cytoplasmic Domains
Enkvetchakul, D., Jeliazkova, I., Bhattacharyya, J., & Nichols, C. G. (2007) · The Journal of General Physiology · doi:10.1085/jgp.200709764 · Cited by 53
Thomas, H. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh144 · Cited by 51
“Since activating mutations in the Kcnj11 gene have been associated with permanent neonatal diabetes (46), the negative effect of HNF6, HNF4a and HNF1b on Kcnj11 expression could play a crucial role for regulated insulin secretion.”
BackgroundBeta‐Cell Ion Channels and Their Role in Regulating Insulin Secretion
Thompson, B. M., & Satin, L. S. (2021) · Comprehensive physiology · doi:10.1002/cphy.c210004 · Cited by 60
Rubio‐Cabezas, O., Klupa, T., & Malecki, M. T. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02409.x · Cited by 54
Shalev, S. A., Tenenbaum‐Rakover, Y., Horovitz, Y., Paz, V. P., Ye, H., Carmody, D., Highland, H. M., Boerwinkle, E., Hanis, C. L., Muzny, D. M., et al. (2013) · Pediatric Diabetes · doi:10.1111/pedi.12086 · Cited by 49
“We screened our proband for mutations in EIF2AK3 as well as other genes including KCNJ11 and ABCC8, as mutations in these genes are among the most common causes of permanent neonatal diabetes (8), and some patients also have severe developmental delay and muscle weakness, epilepsy, and mild dysmorphic features (9, 10).”
Okamoto, K., Iwasaki, N., Doi, K., Noiri, E., Iwamoto, Y., Uchigata, Y., Fujita, T., & Tokunaga, K. (2012) · Diabetes · doi:10.2337/db11-1201 · Cited by 49
“Gain-of-function mutations in KCNJ11 result in a larger b-cell KATP current at a given glucose concentration and thereby reduce or stop glucose-dependent depolarization and Ca influx (22,23).”
BackgroundMeta-analysis of association of common variants in the KCNJ11-ABCC8 region with type 2 diabetes
Qin, L., Lv, Y., & Huang, Q. (2013) · Genetics and Molecular Research · doi:10.4238/2013.august.20.1 · Cited by 50
“About 30% of patients with permanent neonatal diabetes were found to be due to activating KCNJ11 mutations (Gloyn et al., 2004).”
BackgroundMeyre, D., Boutin, P., Tounian, A., Deweirder, M., Aout, M., Jouret, B., Heude, B., Weill, J., Tauber, M., Tounian, P., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1468 · Cited by 56
Bahi‐Buisson, N., Sabbagh, S., Soufflet, C., Escande, F., Boddaert, N., Valayannopoulos, V., Bellanné‐Chantelot, C., Lascelles, K., Dulac, O., Plouin, P., et al. (2008) · Seizure · doi:10.1016/j.seizure.2008.01.005 · Cited by 49
Martin, G. M., Rex, E. A., Devaraneni, P. K., Denton, J. S., Boodhansingh, K. E., León, D. D. D., Stanley, C. A., & Shyng, S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.749366 · Cited by 51
“The ability of the channel to respond to ATP inhibition and MgADP stimulation is critical for its physiological function to ensure correct insulin secretion response (7, 36, 37).”
BackgroundGenetic causes and treatment of neonatal diabetes and early childhood diabetes
Barbetti, F., & D'Annunzio, G. (2018) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2018.06.008 · Cited by 48
Molecular genetics goes to the diabetes clinic
Hattersley, A. T. (2005) · Clinical Medicine · doi:10.7861/clinmedicine.5-5-476 · Cited by 47
Self-citationMasia, R., De Leon, D. D., MacMullen, C., McKnight, H., Stanley, C. A., & Nichols, C. G. (2007) · Diabetes · doi:10.2337/db06-1746 · Cited by 48
“Activating mutations in the pancreatic KATP channel lead to -cell underexcitability and suppression of insulin secretion and underlie permanent and transient forms of neonatal diabetes mellitus (8,9), with the most severe forms associated with extrapancreatic symptoms (Developmental Delay, Epilepsy, and Neonatal Diabe…”
BackgroundMechanistic insights on KATP channel regulation from cryo-EM structures
Driggers, C., & Shyng, S. (2022) · The Journal of General Physiology · doi:10.1085/jgp.202113046 · Cited by 51
“Since the discovery that the gain of function KATP mutations cause neonatal diabetes (Gloyn et al., 2004; Koster et al., 2000), they have also become the first-line medications for the affected patients (Pipatpolkai et al., 2020).”
Two decades since the fetal insulin hypothesis: what have we learned from genetics?
Hughes, A. E., Hattersley, A. T., Flanagan, S. E., & Freathy, R. M. (2021) · Diabetologia · doi:10.1007/s00125-021-05386-7 · Cited by 57
Self-citationHuman Pluripotent Stem Cells to Model Islet Defects in Diabetes
Balboa, D., Iworima, D. G., & Kieffer, T. J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.642152 · Cited by 45
K channel interaction with adenine nucleotides
Matsuo, M., Kimura, Y., & Ueda, K. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.11.021 · Cited by 58
Neonatal diabetes mellitus: Insulin pump as an alternative management strategy
Bharucha, T., Brown, J. J., McDonnell, C. M., Gebert, R., McDOUGALL, P. N., Cameron, F. J., Werther, G. A., & Zacharin, M. (2005) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2005.00696.x · Cited by 47
Edghill, E. L., Gloyn, A. L., Gillespie, K. M., Lambert, A. P., Raymond, N. T., Swift, P. G. F., Ellard, S., Gale, E. A., & Hattersley, A. T. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2998 · Cited by 47
“R201C is likely to be an etiological mutation, as it has previously been reported in a subject with PNDM (1).”
BackgroundResultInfluentialSelf-citationLiu, L., Nagashima, K., Yasuda, T., Liu, Y., Hu, H., He, G., Feng, B., Zhao, M., Zhuang, L., Zheng, T., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-3031-9 · Cited by 47
“Mutated KCNJ11 with R27H or R192H markedly reduced ATP sensitivity (E23K>R27H>C42R>R192H>R201H), but no ATPsensitive potassium channel currents were detected in the loss-of-function S116F117del channel in vitro.”
BackgroundResultInfluentialPharmacogenetics and personalized treatment of type 2 diabetes
Semiz, S., Dujić, T., & Čaušević, A. (2013) · Biochemia Medica · doi:10.11613/bm.2013.020 · Cited by 54
“2 mutations cause dominant ND by reducing the ability of ATP to block KATP channel (13), hyperpolarizing the β-cells, and preventing insulin secretion.”
BackgroundKATP Channel Pharmacogenomics: From Bench to Bedside
Sattiraju, S., Reyes, S., Kane, G. C., & Terzic, A. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100378 · Cited by 46
“mutation), result in ATP-insensitive channels that respond to sulfonylureas with channel closure and insulin release.(8)”
BackgroundInfluentialAshcroft, F. M. (2023) · Diabetes · doi:10.2337/dbi22-0030 · Cited by 54
“Electrophysiological studies revealed that most mutant channels could still be closed by sulfonylureas (25,26,43,44).”
BackgroundSelf-citationSuzuki, S., Koga, M., Amamiya, S., Nakao, A., Wada, K., Okuhara, K., Hayano, S., Sarhat, A. R., Takahashi, H., Matsuo, K., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2211-8 · Cited by 45
“2 subunit of the ATP-sensitive potassium channel of pancreatic beta cells, with onset at a mean age of 7 weeks [3, 4].”
BackgroundSmeland, M. F., McClenaghan, C., Roessler, H. I., Savelberg, S. M. C., Hansen, G. Å. M., Hjellnes, H., Arntzen, K. A., Müller, K. I., Rosenberger, A. D., Harter, T. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12428-7 · Cited by 48
Role of KATP channels in protection against neuronal excitatory insults
Soundarapandian, M. M., Zhong, X., Peng, L., Wu, D., & Lu, Y. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04963.x · Cited by 50
Klupa, T., Skupien, J., Mirkiewicz-Sieradzka, B., Gach, A., Noczynska, A., Zubkiewicz-Kucharska, A., Szalecki, M., Kozek, E., Nazim, J., Mlynarski, W., et al. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0165 · Cited by 46
Proks, P., de Wet, H., & Ashcroft, F. M. (2013) · Diabetes · doi:10.2337/db13-0531 · Cited by 47
Self-citationTransient neonatal diabetes mellitus is associated with a recurrent (R201H) KCNJ11 (KIR6.2) mutation
Colombo, C., Delvecchio, M., Zecchino, C., Faienza, M. F., Cavallo, L., Barbetti, F., & The Early Onset Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetology (2005) · Diabetologia · doi:10.1007/s00125-005-1958-1 · Cited by 45
Jahnavi, S., Poovazhagi, V., Mohan, V., Bodhini, D., Raghupathy, P., Amutha, A., Kumar, P., Adhikari, P., Shriraam, M., Kaur, T., et al. (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2012.01939.x · Cited by 47
“NDM can be either permanent (PNDM) or transient (TNDM).”
BackgroundResultInfluentialSelf-citationSulwon Lecture 2009: The Search for Genetic Risk Factors of Type 2 Diabetes Mellitus
Park, K. S. (2011) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2011.35.1.12 · Cited by 54
“Gain-offunction mutations of KCNJ11 open the potassium channel and inhibit the depolarization of β-cells, leading to a defect in insulin secretion [10].”
BackgroundType 2 diabetes mellitus: from genes to disease.
Malecki, M. T., & Klupa, T. (2005) · PubMed · Cited by 61
Wang, F., Han, X., Ren, Q., Zhang, X., Han, L., Luo, Y., Zhou, X., & Ji, L. (2009) · PubMed · Cited by 47
New Uses for Old Drugs: Neonatal Diabetes and Sulphonylureas
Ashcroft, F. M. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.02.004 · Cited by 48
“Although a few ND mutations increase the whole-cell KATP current by enhancing Cell Metabolism the density of KATP channels in the plasmalemma (Mankouri et al., 2006), most act by decreasing the ability of MgATP to inhibit the channel (Gloyn et al., 2004; reviewed by Ashcroft, 2007).”
BackgroundSelf-citationATP-dependent potassium channels and type 2 diabetes mellitus
Bonfanti, D. H., Alcazar, L. P., Arakaki, P. A., Martins, L. T., Agustini, B. C., Rego, F. G. D. M., & Frigeri, H. R. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.12.026 · Cited by 47
“Because KATP plays a key role in insulin release mechanism, single nucleotide polymorphisms (SNPs) in the genes that code for potassium channel subunits are expected to change glucose homeostasis by compromising insulin secretion [74–77].”
BackgroundLau, H. H., Krentz, N. A. J., Abaitua, F., Perez‐Alcantara, M., Chan, J. W., Ajeian, J., Ghosh, S., Lee, Y., Yang, J., Thaman, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41860-z · Cited by 47
Self-citationβ‐cell hyperexcitability: from hyperinsulinism to diabetes
Nichols, C. G., Koster, J. C., & Remedi, M. S. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00778.x · Cited by 48
Amenable Treatable Severe Pediatric Epilepsies
Pearl, P. L. (2016) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2016.06.004 · Cited by 43
Greeley, S. A. W., Tucker, S. E., Worrell, H. I., Skowron, K. B., Bell, G. I., & Philipson, L. H. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328334f158 · Cited by 49
Disruption of the Ether-à-go-go K+Channel Gene BEC1/KCNH3 Enhances Cognitive Function
Miyake, A., Takahashi, S., Nakamura, Y., Inamura, K., Matsumoto, S., Mochizuki, S., & Katou, M. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0901-09.2009 · Cited by 49
“…neonatal convulsions (Charlier et al., 1998; Singh et al., 1998), temporal lobe epilepsy (Bernard et al., 2004), neonatal diabetes with epilepsy (Gloyn et al., 2004), generalized epilepsy, and paroxysmal dyskinesia (Du et al., 2005), episodic ataxia (D’Adamo et al., 1999), and adult-onset…”
BackgroundChappell, L., Gorman, S., Campbell, F., Ellard, S., Rice, G., Dobbie, A., & Crow, Y. J. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32304 · Cited by 46
Self-citationMetabolic Causes of Epileptic Encephalopathy
Yu, J. Y., & Pearl, P. L. (2013) · Epilepsy Research and Treatment · doi:10.1155/2013/124934 · Cited by 44
De Silva, N. M. G., & Frayling, T. M. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328334fdb6 · Cited by 43
Self-citationTarasov, A. I., Welters, H. J., Senkel, S., Ryffel, G. U., Hattersley, A. T., Morgan, N. G., & Ashcroft, F. M. (2006) · Diabetes · doi:10.2337/db06-0637 · Cited by 43
“The observation that a glucose challenge fails to elicit a rise in plasma C-peptide or insulin in patients carrying neonatal diabetes mutations is consistent with this idea (3,5,9,10).”
ResultSelf-citationThe role of pancreatic imaging in monogenic diabetes mellitus
Haldorsen, I. S., Ræder, H., Vesterhus, M. N., Molven, A., & Njølstad, P. R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.197 · Cited by 43
Self-citationVelíšek, L., Velíšková, J., Chudomel, O., Poon, K., Robeson, K. R., Marshall, B., Sharma, A. K., & Moshé, S. L. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3195-08.2008 · Cited by 41
Wambach, J., Marshall, B. A., Koster, J. C., White, N. H., & Nichols, C. G. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00557.x · Cited by 41
“Results We report a term male, born to a 24-yr-old mother diagnosed with PNDM at 10 wk of age.”
BackgroundInfluentialMembrane Ion Channels and Diabetes
Proks, P., & Lippiat, J. D. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206775474431 · Cited by 44
Self-citationThe transcription factor 7-like 2 gene and increased risk of type 2 diabetes: an update
Lyssenko, V. (2008) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328304d970 · Cited by 47
Monogenic diabetes in children and young adults: Challenges for researcher, clinician and patient
Slingerland, A. S. (2006) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-006-9014-0 · Cited by 42
“The most severe is the Developmental delay early onset generalised Epilepsy and Neonatal Diabetes (DEND) syndrome [25].”
Self-citationTooth Discoloration in Patients With Neonatal Diabetes After Transfer Onto Glibenclamide
Kumaraguru, J., Flanagan, S. E., Greeley, S. A. W., Nuboer, R., Støy, J., Philipson, L. H., Hattersley, A. T., & Rubio-Cabezas, O. (2009) · Diabetes Care · doi:10.2337/dc09-0280 · Cited by 41
“2 subunit of the ATPsensitive potassium (KATP) channel, are the most common known cause of permanent neonatal diabetes (1, 2).”
BackgroundMethodSelf-citationKir6.2 Mutations Associated With Neonatal Diabetes Reduce Expression of ATP-Sensitive K+ channels
Lin, C.-W., Lin, Y., Yan, F.-F., Casey, J., Kochhar, M., Pratt, E. B., & Shyng, S. (2006) · Diabetes · doi:10.2337/db05-1571 · Cited by 41
“Our observation that R201H homomeric channels are poorly expressed (or nonexistent) at the cell surface may help explain why little change in channel ATP sensitivity was observed under heterozygous expression (11,18,21).”
BackgroundMethodInfluentialSlingerland, A. S., & Hattersley, A. T. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0201 · Cited by 41
Self-citationDissection of type 2 diabetes: a genetic perspective
Bonnefond, A., Florez, J. C., Loos, R. J. F., & Froguel, P. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00339-5 · Cited by 54
Roles of lncRNAs in pancreatic beta cell identity and diabetes susceptibility
Pullen, T. J., & Rutter, G. A. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00193 · Cited by 44
Gönen, M. S., Arıkoğlu, H., Kaya, D. E., Özdemir, H., İpekçi, S. H., Arslan, A., Kayış, S. A., & Göğebakan, B. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.06.001 · Cited by 44
Molecular genetic testing of patients with monogenic diabetes and hyperinsulinism
Bennett, J. T., Vasta, V., Zhang, M., Narayanan, J., Gerrits, P., & Hahn, S. H. (2014) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2014.12.304 · Cited by 41
Shepherd, M. H., Brook, A., Chakera, A. J., & Hattersley, A. T. (2017) · Diabetic Medicine · doi:10.1111/dme.13388 · Cited by 43
“If the fetus has inherited the genetic mutation from either the mother or father, reduced fetal insulin secretion results in low birth weight, (median 2580g at median 39 weeks’ gestation) [44-46].”
Self-citationThe &Bgr;-Cell in Type 2 Diabetes and in Obesity
Rutter, G. A., & Parton, L. E. (2008) · KARGER eBooks · doi:10.1159/000115360 · Cited by 46
Bennett, K., James, C. T., Almutair, A., Al-Shaikh, H., Sinani, A. A., & Hussain, K. (2010) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2010.00683.x · Cited by 44
KATP channelopathies in the pancreas
Remedi, M. S., & Koster, J. C. (2009) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0756-x · Cited by 47
Cooper, P., Sala‐Rabanal, M., Lee, S., & Nichols, C. G. (2015) · The Journal of General Physiology · doi:10.1085/jgp.201511495 · Cited by 45
Modulation of Ionic Channels and Insulin Secretion by Drugs and Hormones in Pancreatic Beta Cells
Velasco, M., Díaz‐García, C. M., Larqué, C., & Hiriart, M. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.103861 · Cited by 43
Váradi, A., Grant, A., McCormack, M. D., Nicolson, T. J., Magistri, M., Mitchell, K. J., Halestrap, A. P., Yuan, H., Schwappach, B., & Rutter, G. A. (2006) · Diabetologia · doi:10.1007/s00125-006-0257-9 · Cited by 41
Recent development in pharmacogenomics: from candidate genes to genome-wide association studies
Grant, S. F., & Hakonarson, H. (2007) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.7.4.371 · Cited by 40
Proks, P., Girard, C., Bævre, H., Njølstad, P. R., & Ashcroft, F. M. (2006) · Diabetes · doi:10.2337/db05-1420 · Cited by 40
“Previous studies (3,19) have shown that all Kir6.”
BackgroundSelf-citationBonnefond, A., & Semple, R. K. (2022) · Diabetologia · doi:10.1007/s00125-022-05720-7 · Cited by 44
Neonatal diabetes mellitus: from understudy to center stage
Sperling, M. A. (2005) · Current Opinion in Pediatrics · doi:10.1097/01.mop.0000170517.20025.51 · Cited by 39
Hyperinsulinism and Diabetes: Genetic Dissection of β Cell Metabolism-Excitation Coupling in Mice
Remedi, M. S., & Nichols, C. G. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.10.011 · Cited by 39
“The data from human NDM patients are entirely consistent: monogenic NDM is caused by loss of glucokinase and by GOF mutations in KATP (Gloyn et al., 2004; Gloyn, 2003a).”
WITHDRAWN: Reprint of: Classification of diabetes mellitus
Adler, A., Bennett, P., Chair, S. C., Gregg, E., Venkat Narayan, K. M., Schmidt, M. I., Sobngwi, E., Tajima, N., Tandon, N., Unwin, N., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108972 · Cited by 38
RetractedHulpke, S., Tomioka, M., Kremmer, E., Ueda, K., Abele, R., & Tampé, R. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1005-6 · Cited by 38
“2 [41, 42].”
Devaraneni, P. K., Martin, G. M., Olson, E. M., Zhou, Q., & Shyng, S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.634576 · Cited by 41
“Contrarily, gain-of-function mutations lead to neonatal diabetes (7); although these mutations frequently cause aberrant channel gating (1), they can also alter channel expression to affect presentation of the disease allele (8–10).”
BackgroundDiabetes: Is There a Future for Pharmacogenomics Guided Treatment?
Pearson, E. R. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1484 · Cited by 42
“In these patients, sulfonylureas used at high dose (2–4 times the maximum adult dose/kg) are able to close the mutant KATP channels and stimulate insulin secretion.(11) This work led to the successful transition off lifelong insulin treatment onto sulfonylurea treatment in 90% of patients with NDM.”
BackgroundSelf-citationNext generation sequencing targeted gene panel in Greek MODY patients increases diagnostic accuracy
Tatsi, E., Kanaka‐Gantenbein, C., Scorilas, A., Chrousos, G. P., & Sertedaki, A. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12931 · Cited by 40
Striessnig, J. (2021) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2021.634760 · Cited by 44
“By keeping pancreatic β-cells hyperpolarized they prevent insulin release and cause permanent neonatal diabetes and in about 20% of patients also neurodevelopmental delay (Gloyn et al., 2004; De Franco et al., 2020).”
BackgroundNeonatal diabetes in Ukraine: incidence, genetics, clinical phenotype and treatment
Globa, E., Zelinska, N., Mackay, D., Temple, I. K., Houghton, J., Hattersley, A. T., Flanagan, S. E., & Ellard, S. (2015) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0170 · Cited by 39
Self-citationFunctional analysis of Rfx6 and mutant variants associated with neonatal diabetes
Pearl, E. J., Jarikji, Z., & Horb, M. E. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2010.12.043 · Cited by 46
“, 2005), KCNJ11 (Craig et al., 2009; Gloyn et al., 2004; Shimomura et al., 2010) and ABCC8 (Babenko et al.”
BackgroundInfluentialBahi‐Buisson, N., Eisermann, M., Nivot, S., Bellanné‐Chantelot, C., Dulac, O., Bach, N., Plouin, P., Chiron, C., & de Lonlay, P. (2007) · Journal of Child Neurology · doi:10.1177/0883073807306272 · Cited by 39
“Infantile spasms could also be related to perinatal factors such as intrauterine growth retardation and low birth weight,(12,13) which are almost always features in DEND syndrome and are related to an in utero insulin secretion insufficiency.(1) Our patient presented with severe intrauterine growth retardation as well…”
BackgroundInfluentialGenetic Analysis and Follow-Up of 25 Neonatal Diabetes Mellitus Patients in China
Cao, B., Gong, C., Wu, D., Lu, C., Liu, F., Liu, X., Zhang, Y., Gu, Y., Qi, Z., Li, X., et al. (2015) · Journal of Diabetes Research · doi:10.1155/2016/6314368 · Cited by 37
“Therefore, molecular diagnosis is vital not only in accurate typing but also for better prognostication [5].”
BackgroundMetabolic etiologies in West syndrome
Salar, S., Moshé, S. L., & Galanopoulou, A. S. (2018) · Epilepsia Open · doi:10.1002/epi4.12102 · Cited by 41
“Therefore, epilepsy, including IS when present, was suggested to be linked to the genetic defect in DEND syndrome, rather than the outcome of neonatal diabetes.(77,79,80) The rarity of reported cases of IS in DEND and the lack of cohorts exploring the incidence of IS in patients with DEND do not allow for strong argum…”
BackgroundTargeted sequencing identifies novel variants in common and rare MODY genes
de Santana, L. S., Caetano, L. A., Costa‐Riquetto, A. D., Franco, P. C., Dotto, R. P., Reis, A. F., Weinert, L. S., Silveiro, S. P., Vendramini, M. F., do Prado, F. A., et al. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.962 · Cited by 41
“…& Hattersley, 2006; Faguer et al., 2011; Granberg et al., 2012; Hoskins et al., 2007; Oram et al., 2010), in patients with DM and renal/pancreatic/genitourinary dysgenesis, a functional study (Granberg et al., 2012) showed no difference in comparison between the variant and its wild‐type allele.”
BackgroundMolecular cell biology of KATPchannels: implications for neonatal diabetes
Smith, A. J., Taneja, T. K., Mankouri, J., & Sivaprasadarao, A. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399407000403 · Cited by 45
Acute Sulfonylurea Therapy at Disease Onset Can Cause Permanent Remission of KATP-Induced Diabetes
Remedi, M. S., Agapova, S. E., Vyas, A. K., Hruz, P. W., & Nichols, C. G. (2011) · Diabetes · doi:10.2337/db11-0538 · Cited by 36
“2 and the regulatory SUR1 subunits of the KATP channel are major causes of both PNDM and remitting-relapsing TNDM in humans (4,8,13,15,25,34,35).”
BackgroundKATP Channel Mutations and Neonatal Diabetes
Shimomura, K., & Maejima, Y. (2017) · Internal Medicine · doi:10.2169/internalmedicine.8454-16 · Cited by 41
“2 (KCNJ11) and SUR1 (ABCC8) mutations (23-32).”
BackgroundDiagnosis, Therapy and Follow-up of Diabetes Mellitus in Children and Adolescents
Neu, A., Bürger-Büsing, J., Danne, T., Dost, A., Holder, M., Holl, R. W., Holterhus, P., Kapellen, T. M., Karges, B., Kordonouri, O., et al. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0869-0210 · Cited by 38
“[211] Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, Howard N, Srinivasan S, Silva JM, Molnes J, Edghill EL, Frayling TM, Temple IK, Mackay D, Shield JP, Sumnik Z, van Rhijn A, Wales JK, Clark P, Gorman S, Aisenberg J, Ellard S, Njolstad PR, Ashcroft FM, Hattersley AT.”
BackgroundEllard, S., Colclough, K., Patel, K. A., & Hattersley, A. T. (2019) · Journal of Clinical Investigation · doi:10.1172/jci133516 · Cited by 38
Self-citationSpectrum of Phenotypes and Causes of Type 2 Diabetes in Children
SHAH, A. S., Nadeau, K. J., Dabelea, D., & REDONDO, M. J. (2022) · Annual Review of Medicine · doi:10.1146/annurev-med-042120-012033 · Cited by 39
“For instance, the E23K variant in KCNJ11, mutation of which causes permanent neonatal diabetes mellitus (82), increases type 2 diabetes risk (83, 84), possibly via reduced glucose-induced insulin secretion (85).”
Background
Metadata
- Authors
- Gloyn, A. L., Pearson, E. R., Antcliff, J. F., Proks, P., Bruining, G. J., Slingerland, A. S., Howard, N., Srinivasan, S., Silva, J. M. C. L., Molnes, J., Edghill, E. L., Frayling, T. M., Temple, I. K., Mackay, D., Shield, J. P. H., Sumnik, Z., van Rhijn, A., Wales, J. K. H., Clark, P., Gorman, S., Aisenberg, J., Ellard, S., Njølstad, P. R., Ashcroft, F. M., & Hattersley, A. T.
- Affiliations
- University of Exeter (GB)
- University of Oxford (GB)
- Erasmus MC - Sophia Children’s Hospital (NL)
- Children's Hospital at Westmead (AU)
- University of Bergen (NO)
- National Health Service (GB)
- Salisbury District Hospital (GB)
- Sheffield Children's Hospital (GB)
- St. Luke's Hospital (GB)
- Hackensack University Medical Center (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-04-29
- Volume
- 350
- Issue
- 18
- Pages
- 1838-1849
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2012515461
- Cited by
- 1,137
- References
- 38
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 31 · 2023: 44 · 2022: 37 · 2021: 49 · 2020: 33 · 2019: 50 · 2018: 57 · 2017: 51 · 2016: 55 · 2015: 49 · 2014: 60 · 2013: 55 · 2012: 45
- FWCI
- 70.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- permanent neonatal diabetes, Kir6.2, KCNJ11, ATP-sensitive potassium channels, activating mutations, missense mutations, SUR1, tolbutamide, glucose-stimulated insulin secretion, developmental delay, muscle weakness, epilepsy, genetic diagnosis
- MeSH terms
- Developmental Disabilities, Diabetes Mellitus, DNA Mutational Analysis, Epilepsy, Face, Female, Heterozygote, Humans, Infant, Newborn, Islets of Langerhans, Male, Mutation, Pedigree, Sequence Analysis, DNA, Potassium Channels, Inwardly Rectifying
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.